Effects of Different Surface Treatments on Bond Strength of Resin Cement to Machined Pure Titanium.

PURPOSE: To investigate the effects of grit blasting, acidic or alkaline/heat treatments, and metal primer application on the shear bond strength (SBS) of resin cement to machined commercially pure titanium (CP-Ti). MATERIALS AND METHODS: Titanium plates were machined and received one of the following treatments: grit-blasting (GB), or grit-blasting followed by either acidic treatment (GB/AC) or alkaline/heat treatment (GB/AH). The specimens were randomly divided into 4 groups and treated with Rely X Ceramic Primer (RCP), Z Prime Plus (ZPP), and Alloy Primer (ALP), or without primer as the control. The pairs of titanium plates were cemented together with the Rely X Unicem cement. SBS was measured before and after thermocycling between 5°C and 55°C for 5000 cycles. RESULTS: SEM observation showed that honeycomb-shaped pores formed on the surface of machined CP-Ti after GB/AC treatment, whereas a uniform net-like pattern formed after GB/AH treatment. In descending order, the surface roughness was GB, GB/AC, and GB/AH. The GB/AH group showed the highest SBS among all the treatments. As for primers, ALP group showed the highest SBS, while the RCP group showed the lowest. GB followed by ALP presented the highest SBS. CONCLUSION: A fine, uniform network structure was formed on the surface of CP-Ti following GB/AH treatment, providing an effective micromechanical interlocking mechanism for resin bonding. At the same time, after AH treatment, the -OH formed on the surface of the machined CP-Ti triggered a chemical reaction with the acid monomers in the resin adhesives, creating a chemical bond. As a result, GB/AH treatment significantly improved the bond strength relative to GB/AC treatment. In addition, ALP treatment facilitated the formation of hydrogen bonds, which further improved the chemical bond strength. Finally, the combination of the effects mentioned above resulted in the most robust bond between machined CP-Ti and the resin adhesives.

Acupuncture for Treatment of Erectile Dysfunction: A Systematic Review and Meta-Analysis

PURPOSE: To assess the effectiveness and safety of acupuncture for erectile dysfunction (ED). MATERIALS AND METHODS: We searched six major English and Chinese databases included randomized controlled trials (RCTs) testing acupuncture alone or in combination for ED. Dichotomous data were presented as risk ratio (RR) and continuous data were presented as mean difference (MD) both with 95% confidence interval (CI). The Revman (v.5.3) was used for data analyses. Quality of evidence across studies was assessed by the online GRADEpro tool. RESULTS: We identified 22 RCTs, fourteen of them involving psychogenic ED. Most of the included RCTs had high or unclear risk of bias. There was no difference between electro-acupuncture and sham acupuncture with electrical stimulation on the rate of satisfaction and self-assessment (RR, 1.50; 95% CI, 0.71–3.16; 1 trial). Acupuncture combined with tadalafil appeared to have better effect on increasing cure rate (RR, 1.31; 95% CI, 1.00–1.71; 2 trials), and International Index of Erectile Function-5 scores (MD, 5.38; 95% CI, 4.46–6.29; 2 trials). When acupuncture plus herbal medicine compared with herbal medicine alone, the combination therapy showed significant better improvement in erectile function (RR, 1.68; 95% CI, 1.31–2.15; 7 trials). Only two trials reported facial red and dizziness cases, and needle sticking and pruritus cases in acupuncture group. CONCLUSIONS: Low quality evidence shows beneficial effect of acupuncture as adjunctive treatment for people mainly with psychogenic ED. Safety of acupuncture was insufficiently reported. The findings should be confirmed in large, rigorously designed and well-reported trials.

Songling Xuemaikang Capsule () for primary hypertension: A systematic review of randomized controlled trials / 中国结合医学杂志

<p><b>OBJECTIVE</b>To evaluate the effectiveness and safety of Songling Xuemaikang Capsule (, SXC) for the treatment of primary hypertension.</p><p><b>METHODS</b>An extensive search including Cochrane Library, PubMed, Cochrane Central Register of Controlled Trials (CENTRAL), Chinese Biomedical Literature Database (CBM), Chinese National Knowledge Infrastructure (CNKI), Chinese Scientific Journal Database (VIP), KoreaMed, Japanese database, and online clinical trial registry websites was performed up to February 2013. Randomized controlled trials (RCTs) regarding SXC for the treatment of primary hypertension were searched without no language restrictions. The quality of each trial was assessed according to the Cochrane Reviewers' Handbook 5.0, and RevMan 5.0 provided by the Cochrane Collaboration.</p><p><b>RESULT</b>A total of 17 RCTs involving 1,778 patients were included. Meta-analysis showed that there was no significant difference between SXC and antihypertensive agents on systolic blood pressure [mean difference (MD): -0.10 [-4.83, 4.63]; P=0.97] and diastolic blood pressure (MD: 1.00 [-1.16, 3.16]; P=0.36), but SXC combined with antihypertensive drugs was more effective in lowering systolic blood pressure (MD: -6.17 [-7.86, -4.49]; P<0.00001) and diastolic blood pressure (MD: -7.24 [-8.62, -5.85]; P<0.00001) compared with the antihypertensive drugs alone.</p><p><b>CONCLUSIONS</b>SXC used alone or combined with antihypertensive drugs appear to be an effective treatment for lowering elevated blood pressure and improving symptoms in patients with primary hypertension. However, the conclusion cannot be drawn definitely due to the poor quality of the included studies. There is still an urgent need for well-designed, long-term studies to address the benefits of SXC for treating primary hypertension.</p>

Chinese medicine clinical trial protocol design and report specifications / 中国中西医结合杂志

Clinical trial protocol is the document that illustrates the background of a clinical trial, theoretic basis, objective, design, methods, and organization, as well as statistical calculating, implement, and conditions for completion. Clinical trial protocol is the basic measure for ensuring the validity of scientific results and reducing bias. In order to optimize the design of clinical trial protocol, we generalize main problems in Chinese medicine clinical trials, key points of clinical trial protocol, as well as report standards.